Physostigmine

butyrylcholinesterase ; Homo sapiens







93 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33317802 Perioperative use of physostigmine to reduce opioid consumption and peri-incisional hyperalgesia: a randomised controlled trial. 2021 Mar 1
2 32729530 Precision medicine in Alzheimer's disease: An origami paper-based electrochemical device for cholinesterase inhibitors. 2020 Oct 1 1
3 31517530 Computational insight into the anticholinesterase activities and electronic properties of physostigmine analogs. 2019 Aug 1
4 30245349 2-Furoic piperazide derivatives as promising drug candidates of type 2 diabetes and Alzheimer's diseases: In vitro and in silico studies. 2018 Dec 1
5 26589572 Pharmacological management of anticholinergic delirium - theory, evidence and practice. 2016 Mar 1
6 26772968 Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine. 2016 Oct 2
7 26318401 Synthesis, molecular docking, acetylcholinesterase and butyrylcholinesterase inhibitory potential of thiazole analogs as new inhibitors for Alzheimer disease. 2015 Oct 1
8 24236981 Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease. 2013 Dec 1
9 20047897 Interaction of physostigmine and alfentanil in a human pain model. 2010 Mar 1
10 20144867 Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities. 2010 Mar 1 1
11 19416629 M(1) and M(3) muscarinic receptors are involved in the release of urinary bladder-derived relaxant factor. 2009 May 1
12 19583746 The cholinesterase inhibitor physostigmine for the local treatment of dry mouth: a randomized study. 2009 Jun 1
13 21204339 The Revival of Scopolamine Reversal for the Assessment of Cognition-Enhancing Drugs 2009 1
14 17655781 Physostigmine and anaesthesia emergence delirium in preschool children: a randomized blinded trial. 2008 Jan 1
15 17950687 Microcalorimetric study of the inhibition of butyrylcholinesterase by carbamates. 2008 Feb 15 1
16 18077465 Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health. 2008 Feb 1
17 18577377 The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesis. 2008 Sep 25 1
18 17658455 Intraoral stimulation of salivary secretion with the cholinesterase inhibitor physostigmine as a mouth spray: a pilot study in healthy volunteers. 2007 Nov 2
19 16278840 In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. 2006 Jan 1
20 16508314 Growth hormone responses to low-dose physostigmine in elderly vs. young women and men. 2006 1
21 16958557 The early toxicology of physostigmine: a tale of beans, great men and egos. 2006 1
22 15974893 An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. 2005 Jul 1
23 14766981 Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation. 2004 Feb 17 1
24 12682768 [Atypical tonic pupil as a complication of chickenpox infection]. 2003 Apr 1
25 12958052 Reduction of sleep-disordered breathing after physostigmine. 2003 Nov 15 2
26 11927192 Sexual diergism of hypothalamo-pituitary-adrenal cortical responses to low-dose physotigmine in elderly vs. young women and men. 2002 May 1
27 12073883 Eptastigmine, nicotinamide and nicotinic acid determination using an inhibition enzyme sensor; application to pharmaceutical analysis. 2002 Apr 1
28 12083745 Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor. 2002 May 1
29 12473087 Effects of cholinergic enhancement on conditioning-related responses in human auditory cortex. 2002 Dec 1
30 11521162 Release of non-neuronal acetylcholine from the human placenta: difference to neuronal acetylcholine. 2001 Sep 1
31 11697469 The esterase-like activity of serum albumin may be due to cholinesterase contamination. 2001 Oct 1
32 11767272 Stimulation of minor salivary glands by intraoral treatment with the cholinesterase inhibitor physostigmine in man. 2001 Dec 2
33 11256231 Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. 2000 Oct 3
34 10192824 Pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration in normal women and men. 1999 May 1
35 10372954 Neuroendocrine responses to intravenous infusion of physostigmine in patients with Alzheimer disease. 1999 Apr-Jun 1
36 10637939 PET studies and cholinergic therapy in Alzheimer's disease. 1999 1
37 10643873 Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects. 1999 Dec 13 1
38 11249555 The pharmacology of donepezil: a new treatment of Alzheimer's disease. 1999 Nov 1
39 9689457 Interactions of cholinergic and glutamatergic neuronal systems in the functional activation of cerebral blood flow response: a PET study in unanesthetized monkeys. 1998 Jun 15 1
40 9880090 Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology. 1998 Dec 1
41 8780856 Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and gender. 1996 Jul 1 1
42 8856831 Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. 1996 Jul 1
43 7554703 Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease. 1995 Sep 1
44 7636741 Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase. 1995 Aug 1
45 7760120 Cholinergic synaptic transmission between proprioceptive afferents and a hind leg motor neuron in the locust. 1995 Feb 1
46 7874590 Enhanced hypothalamic-pituitary-adrenocortical axis responses to physostigmine in normal aging. 1995 Mar 1
47 8749612 Treatment of Alzheimer disease by continuous intravenous infusion of physostigmine. 1995 Winter 2
48 8848515 Lack of cholinergic regulation of vasopressin and norepinephrine responses to hypertonic saline in humans. 1995 1
49 7816881 Influence of cholinesterase inhibitors on cortical slow-wave activity in aging nonhuman primate. 1994 Sep 2
50 7934317 Oral administration of heptylphysostigmine in healthy volunteers: a preliminary study. 1994 Jun 2